A Phase I/II study to evaluate AZD5851 in GPC3+ advanced/recurrent hepatocellular carcinoma

Trial Identifier: D7670C00001
Sponsor: AstraZeneca
Start Date: December 2023
Primary Completion Date: December 2027
Study Completion Date: December 2027
Condition: Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations